Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| ELLA-CS , sro | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
A non-randomized prospective clinical, pilot study in a single centre assessing the safety and feasibility of the esophageal biodegradable covered stent for refractory benign esophageal strictures with or without fistulae
A non-randomized prospective clinical, pilot study in a single centre assessing the safety and feasibility of the esophageal biodegradable covered stent for refractory benign esophageal strictures with or without fistulae. The follow-up will be 6 months form implantation. After 3 months a control endoscopy will take place to evaluate stent and degradation process.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BD-Covered stent | Experimental | Device: BD-Covered stent for refractory benign esophageal strictures with of without fistulae |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BD-Covered esophageal stent | Device | a biodegradable covered stent is implanted to achieve a long-term relieve of dysphagia in refractory benign esophageal strictures |
|
| Measure | Description | Time Frame |
|---|---|---|
| Incidence of treatment associated adverse events during follow-up (safety) | Short term (within 7 days after treatment) and long term (after 7 days) major complications and minor complications. Major complications are defined as life threatening and severe complications such as perforation, haemorrhage, fistula formation and severe pain. Minor complications are defined as non-life threatening or moderately severe pain and gastroesophageal reflux. | 6 months |
| BD-Covered stent placement (feasibility): (1) ease of deployment at intended esophageal location and, (2) incidence of device related adverse events at moment of stent placement | Technical success is defined as ease of deployment and placement of the BD-Covered stent at the required esophageal location. | 1 day |
| Measure | Description | Time Frame |
|---|---|---|
| Esophageal pain, measured with VAS during follow-up after stent placement | Pain will be measured with the VAS during follow-up | 6 months |
| Recurrent dysphagia, measured with Ogilvie dysphagia score, during follow-up |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Bram Vermeulen, Drs. | Contact | 0611079557 | +31 | bram.vermeulen@radboudumc.nl |
| Peter SiersemA, Dr. | Contact | 06 547 84 967 | +31 | peter.siersema@radboudumc.nl |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Recurrent dysphagia during follow-up
| 6 months |